These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 2960142)

  • 21. Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma.
    De Lepeleire I; Reiss TF; Rochette F; Botto A; Zhang J; Kundu S; Decramer M
    Clin Pharmacol Ther; 1997 Jan; 61(1):83-92. PubMed ID: 9024176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.
    Zeiger RS; Szefler SJ; Phillips BR; Schatz M; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM;
    J Allergy Clin Immunol; 2006 Jan; 117(1):45-52. PubMed ID: 16387583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of an oral leukotriene antagonist L-649,923 on histamine and leukotriene D4-induced bronchoconstriction in normal man.
    Barnes N; Piper PJ; Costello J
    J Allergy Clin Immunol; 1987 May; 79(5):816-21. PubMed ID: 3553279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of leukotriene antagonists and synthesis inhibitors in man.
    Barnes N; Evans J; Zakrzewski J; Piper P; Costello J
    Prog Clin Biol Res; 1988; 263():393-403. PubMed ID: 2837778
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies of an orally active leukotriene antagonist L-649,923 in normal man.
    Barnes NC; Piper PJ; Costello JF
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1000-2. PubMed ID: 2960141
    [No Abstract]   [Full Text] [Related]  

  • 26. Novel arylthio- and arylsulfonylpropyloxyacetophenones: design and synthesis of L-648,051 and L-649,923, potent antagonists of leukotriene D4.
    Young RN; Jones TR; Atkinson JG; Bélanger P; Champion E; Denis D; DeHaven RN; Ford-Hutchinson AW; Fortin R; Frenette R
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():544-8. PubMed ID: 2959111
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term metaproterenol therapy in asthmatic children.
    Brandon ML
    Chest; 1978 Jun; 73(6 Suppl):1012-3. PubMed ID: 354881
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical trials in acute severe asthma: are type II errors important?
    Ward MJ
    Thorax; 1986 Nov; 41(11):824-9. PubMed ID: 3824268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of parenteral magnesium on pulmonary function, plasma cAMP, and histamine in bronchial asthma.
    Brunner EH; Delabroise AM; Haddad ZH
    J Asthma; 1985; 22(1):3-11. PubMed ID: 2991184
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of indomethacin in asthma: evidence against a role for prostaglandins in its pathogenesis.
    Smith AP
    Br J Clin Pharmacol; 1975 Aug; 2(4):307-9. PubMed ID: 788731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of L-649, 923, an LTD4 antagonist, on phospholipase A2-induced hypotension.
    Cicala C; Sorrentino R; Sorrentino L; Cirino G
    Pharmacol Res; 1990; 22 Suppl 3():83. PubMed ID: 2097660
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of inhaled alpha-blocker on airflow obstruction in asthma.
    Britton J; Ayres J; Cochrane GM
    J R Soc Med; 1981 Sep; 74(9):646-8. PubMed ID: 6457152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Piriprost: a selective inhibitor of leukotriene synthesis.
    Bach MK; Bowman BJ; Brashler JR; Fitzpatrick FA; Griffin RL; Johnson HG; Major NJ; McGuire JC; McNee ML; Richards IM
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():225-7. PubMed ID: 2936098
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacological attempts to modulate leukotriene synthesis in aspirin-induced asthma.
    Nizankowska E; Sheridan AQ; Maile MH; Cross CJ; Czerniawska-Mysik G; Szcezklik A
    Agents Actions Suppl; 1987; 21():203-13. PubMed ID: 3314412
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma.
    Britton JR; Hanley SP; Tattersfield AE
    J Allergy Clin Immunol; 1987 May; 79(5):811-6. PubMed ID: 3571772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukotriene (LT) D4 is involved in antigen-induced asthma: a study with the LTD4 receptor antagonist, MK-571.
    Rasmussen JB; Margolskee DJ; Eriksson LO; Williams VC; Andersson KE
    Ann N Y Acad Sci; 1991; 629():436. PubMed ID: 1952571
    [No Abstract]   [Full Text] [Related]  

  • 37. Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects.
    Phillips GD; Rafferty P; Robinson C; Holgate ST
    J Pharmacol Exp Ther; 1988 Aug; 246(2):732-8. PubMed ID: 3404455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous versus nebulized terbutaline in patients with acute severe asthma; a double-blind randomized study.
    Van Renterghem D; Lamont H; Elinck W; Pauwels R; Van der Straeten M
    Ann Allergy; 1987 Oct; 59(4):313-6. PubMed ID: 3310750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma.
    Britton J; Hanley S; Tattersfield A
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1003-6. PubMed ID: 2960142
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.